deltatrials
Terminated PHASE4 INTERVENTIONAL 10-arm NCT00203996

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

Sleep, Metabolic, and Cardiovascular Dysfunction in Polycystic Ovary Syndrome

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Obstructive Sleep Apnea Polycystic Ovary Syndrome
Interventions REM frag SWS supp continuous positive airway pressure (CPAP) depot leuprolide plus estrogen/progestin replacement pioglitazone
Updated 8 times since 2017 Last updated: Feb 21, 2023 Started: Sep 30, 2003 Primary completion: Jun 30, 2008 Completion: Jun 30, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Did not meet target patient accrual goals

Other terminated trials from National Heart, Lung, and Blood Institute (NHLBI)

See all terminations from National Heart, Lung, and Blood Institute (NHLBI)

Listed as NCT00203996, this PHASE4 trial focuses on Obstructive Sleep Apnea and Polycystic Ovary Syndrome and remains terminated or withdrawn. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 8 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Apr 2023 · 16 months · monthly snapshotTerminated~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Apr 2023 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Dec 2021 — Apr 2023 [monthly]

    Terminated PHASE4

  5. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE4

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

  2. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE4

  3. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE4

    First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
  • National Institutes of Health (NIH)
  • University of Chicago
Data source: University of Chicago

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations